An evaluation of the International Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 55, Issue 8, 2006, Pages 1088-1096

  Lu, Bin ^a,b   Yang, Yehong ^a,b   Song, Xiaoyan ^a,b   Dong, Xuehong ^a,b   Zhang, Zhaoyun ^a,b   Zhou, Linuo ^a,b   Li, Yiming ^a,b   Zhao, Naiqing ^b   Zhu, XiXing ^a,b   Hu, Renming ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CHINESE; CHOLESTEROL BLOOD LEVEL; CLUSTER ANALYSIS; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIET RESTRICTION; FEMALE; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZATION; WAIST CIRCUMFERENCE; WORLD HEALTH ORGANIZATION;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY HEIGHT; BODY WEIGHT; CAROTID ARTERIES; CHINA; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SAMPLING STUDIES; TERMINOLOGY; WORLD HEALTH ORGANIZATION;

EID: 33745894999     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.04.003     Document Type: Article

References (45)

1. Hu G., Qiao Q., Tuomilehto J., et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non diabetic European men and women. Arch Intern Med 164 (2004) 1066-1076
2. Girman C.J., Rhodes T., Mercuri M., et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 93 (2004) 136-141
3. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
4. Malik S., Wong N.D., Franklin S.S., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250
5. Reaven G.M. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
6. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
8. Ford E.S., and Giles W.H. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26 (2003) 575-581
9. Sone H., Mizuno S., Fujii H., et al. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care 28 (2005) 1463-1471
10. The IDF consensus worldwide definition of the metabolic syndrome. [article online], 2005. Available from. http://www.idf.org/webdata/docs/Metsyndrome_Final.pdf [Accessed 4 June 2006]
11. Sone H., Tanaka S., Ishibashi S., et al. The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions: additional analysis from the Japan diabetes complications study. Diabetes Care 29 (2006) 145-147
12. Pignoli P., Tremoli E., Poli A., et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 74 (1986) 1399-1406
13. Salonen R., and Salonen J.T. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis 81 (1990) 33-40
14. Handa N., Matsumoto M., Maeda H., et al. Ultrasonic evaluation of early carotid atherosclerosis. Stroke 21 (1990) 1567-1572
15. de Groot E., Hovingh G.K., Wiegman A., et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 109 Suppl III (2004) 33-38
16. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340 (1999) 14-22
17. Chambless L.E., Heiss G., Folsom A.R., et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987-1993. Am J Epidemiol 146 (1997) 483-494
18. Hodis H.N., Mack W.J., LaBree L., et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 128 (1998) 262-269
19. Bots M.L., Hoes A.W., Koudstaal P.J., et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96 (1997) 1432-1437
20. Wyman R.A., Fraizer M.C., Keevil J.G., et al. Ultrasound-detected plaque of carotid artery as a screening tool for advanced subclinical atherosclerosis. Am Heart J 150 (2005) 1081-1085
21. Xiang H.D. Study on prevalence rates of hypertension and chronic diabetic complications of patients with diabetes. Chin J Epidemiol 23 (2003) 819-821
22. Zhang B., Xiang H.D., Mao W.B., et al. Epidemiological survey of chronic vascular complications of type 2 diabetic in-patients in four municipalities. Acta Acad Med Sin 24 (2002) 452-456
23. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
24. American Diabetes Association. Nephropathy in diabetes. Diabetes Care 27 Suppl 1 (2004) S79-S83
25. Epidemiology of diabetes interventions and complications (EDIC) research group. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Diabetes 48 (1999) 383-390
26. Fried L.P., Borhani N.O., Enright P., et al. The cardiovascular health study: design and rational. Ann Epidemiol 1 (1991) 263-276
27. D'Agostino R.B., Burke G., O'Leary D., et al. Ethnic differences in carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Stroke 27 (1996) 1744-1749
28. Wei M., Gonzalez C., Haffner S.M., et al. Ultrasonography assessed maximum carotid wall thickness in Mexico City residents and Mexican-Americans in San Antonio, TX, association with diabetes and cardiovascular risk factors. Atheroscler Thromb Vasc Biol 16 (1996) 1184-1188
29. Pignoli P. Ultrasound B-mode imaging for arterial wall thickness measurement. Atheroscler Rev 12 (1984) 177-184
30. Poli A., Tremoli E., Colombo A., et al. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients: a new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis 70 (1988) 253-261
31. Salonen R., Seppänen K., Rauramaa R., et al. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Arterioscler Thromb Vasc Biol 8 (1988) 788-792
32. Goya K., Kitamura T., Inaba M., et al. Risk factors for asymptomatic atherosclerosis in Japanese type 2 diabetic patients without diabetic microvascular complications. Metabolism 52 (2003) 1302-1306
33. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
34. Bruno G., Merletti F., Biggeri A., et al. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 27 (2004) 2689-2694
35. Makuyana D., Gomo Z., Munyombwe T., et al. Metabolic syndrome disorders in urban black Zimbabweans with type 2 Diabetes mellitus. Cent Afr J Med 50 (2004) 24-29
36. Alebiosu C.O., and Odusan B.O. Metabolic syndrome in subjects with type-2 diabetes mellitus. J Natl Med Assoc 96 (2004) 817-821
37. Meigs J.B., Wilson P.W., Nathan D.M., et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 52 (2003) 2160-2167
38. The Asia Pacific perspective: redefining obesity and its treatment (February 2000). [article online], 2000. Available from. http://www.wpro.who.int/NR/rdonlyres/0A35147B-B1D5-45A6-9FF2-F7D86608A4D E/0/Redefiningobesity.pdf [Accessed 30 December 2005]
39. Lemieux I., Pascot A., Couillard C., et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small dense LDL) in men?. Circulation 102 (2000) 179-188
40. Lu B., Yang Y., Song X., et al. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health. Obes Res 6 Suppl 2 (1998) 51-209
41. Guerre-Millo M. Adipose tissue hormones. J Endocrinol Invest 25 (2002) 855-861
42. Ardern C.I., Katzmarzyk P.T., Janssen I., et al. Discrimination of health risk by combined body mass index and waist circumference. Obes Res 11 (2003) 135-142
43. Zhu S., Heshka S., Wang Z., et al. Combination of BMI and waist circumference for identifying cardiovascular risk factors in whites. Obes Res 12 (2004) 633-645
44. Wildman R.P., Gu D., Reynolds K., et al. Are waist circumference and body mass index independently associated with cardiovascular disease risk in Chinese adults?. Am J Clin Nutr 82 (2005) 1195-1202
45. Pan W.-H. Metabolic syndrome-an important but complex disease entity for Asians. Acta Cardiol Sin 18 (2002) 24-26